Who has invested in Joyo Pharma?

Regeneron Ventures, Deerfield Management are named among the investors backing Joyo Pharma.

Joyo Pharma Funding: $66M Raised, Series B (2025)

Joyo Pharma funding overview

Joyo Pharma is based in Guangzhou, China. Joyo Pharma has raised $66M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2025. The round record for Joyo Pharma runs through 2025; nothing later has been disclosed. Investors on record include Regeneron Ventures, Deerfield Management. 2 distinct backers are named across the disclosed rounds.

Joyo Pharma at a glance

Total raised: $66M
Latest round: Series B
Latest round date: June 2025
Headquarters: Guangzhou, China
Notable investors: Regeneron Ventures, Deerfield Management

Frequently asked about Joyo Pharma funding

How much has Joyo Pharma raised?: Joyo Pharma has raised $66M in total disclosed funding across the rounds on record.
Who has invested in Joyo Pharma?: Regeneron Ventures, Deerfield Management are named among the investors backing Joyo Pharma.
What was the latest Joyo Pharma funding round?: The most recent disclosed round is a Series B, announced in June 2025.
Where is Joyo Pharma based?: Joyo Pharma is based in Guangzhou, China.
When did Joyo Pharma last raise?: The last disclosed Joyo Pharma round closed in June 2025 at Series B.

Joyo Pharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Guangzhou below to benchmark round size and investor mix.

Joyo Pharma Funding: $66M Raised, Series B (2025)

Joyo Pharma funding overview

Joyo Pharma at a glance

Frequently asked about Joyo Pharma funding

Companies related to Joyo Pharma (22)

Browse related funding lists (4)